{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:33:52Z","timestamp":1776814432510,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bmcl.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T16:30:14Z","timestamp":1557333014000},"page":"1831-1835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Design and synthesis of novel 1-phenyl-3-(5-(pyrimidin-4-ylthio)-1,3,4-thiadiazol- 2-yl)urea derivatives with potent anti-CML activity throughout PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"29","author":[{"given":"Weiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqiong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4946","key":"10.1016\/j.bmcl.2019.05.005_b0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.bmcl.2019.05.005_b0010","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bmcl.2019.05.005_b0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.leu.2402912","article-title":"Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies","volume":"17","author":"Clarkson","year":"2003","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bmcl.2019.05.005_b0020","first-page":"152","article-title":"Chronic myeloid leukemia in 2006: a perspective","volume":"91","author":"Mauro","year":"2006","journal-title":"Heamatologica"},{"key":"10.1016\/j.bmcl.2019.05.005_b0025","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Chronic Myeloid Leukemia (Version 3.2018). https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx. 2019 Accessed 15 January 2019."},{"issue":"1","key":"10.1016\/j.bmcl.2019.05.005_b0030","first-page":"M11","article-title":"Bcr-abl inhibition as a modality of CML therapeutics","volume":"1551","author":"Buchdunger","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.bmcl.2019.05.005_b0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.bmcl.2019.05.005_b0040","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.2011.34.7146","article-title":"Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008","volume":"29","author":"Bjorkholm","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.bmcl.2019.05.005_b0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2011.67","article-title":"The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem\/progenitor cells","volume":"25","author":"Pellicano","year":"2011","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bmcl.2019.05.005_b0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/156800912800673202","article-title":"Emerging therapies in chronic myeloid leukemia","volume":"12","author":"Gora-Tybor","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.bmcl.2019.05.005_b0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2007.07.014","article-title":"A new mutational AKTivation in the PI3K pathway","volume":"12","author":"Brugge","year":"2007","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bmcl.2019.05.005_b0060","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.bmcl.2019.05.005_b0065","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bmcl.2019.05.005_b0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.bmcl.2019.05.005_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"issue":"24","key":"10.1016\/j.bmcl.2019.05.005_b0080","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.bmcl.2019.05.005_b0085","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1535-7163.MCT-05-0410","article-title":"Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor","volume":"5","author":"Albert","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"10.1016\/j.bmcl.2019.05.005_b0090","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1016\/j.bmc.2011.06.022","article-title":"Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors","volume":"19","author":"Li","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2019.05.005_b0095","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1016\/j.ejmech.2011.08.013","article-title":"New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies","volume":"46","author":"Choi","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2019.05.005_h0100","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.bmcl.2005.02.088","article-title":"Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols","volume":"15","author":"Almajan","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"10.1016\/j.bmcl.2019.05.005_h0105","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1021\/jm0201520","article-title":"Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities","volume":"45","author":"Kim","year":"2002","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2019.05.005_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellsig.2011.08.010","article-title":"Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k\/Akt signaling pathway","volume":"24","author":"Wang","year":"2012","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.bmcl.2019.05.005_b0110","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00018-010-0261-6","article-title":"Emerging roles for WNK kinases in cancer","volume":"67","author":"Moniz","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"29","key":"10.1016\/j.bmcl.2019.05.005_b0115","doi-asserted-by":"crossref","first-page":"26653","DOI":"10.1074\/jbc.M502598200","article-title":"Properties of WNK1 and implications for other family members","volume":"280","author":"Lenertz","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19302902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19302902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:28:55Z","timestamp":1760772535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19302902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":24,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0960894X19302902"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.05.005","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel 1-phenyl-3-(5-(pyrimidin-4-ylthio)-1,3,4-thiadiazol- 2-yl)urea derivatives with potent anti-CML activity throughout PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}